Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 11 Apr 2025 15:28 CEST |
PHOTOCURE | Photocure ASA - Notice of the Annual General Meeting 5 May 2025 | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 11 Apr 2025 15:20 CEST |
PHOTOCURE | Photocure ASA: Annual Report 2024 | 20103015 Pharmaceuticals | Annual financial and audit Reports |
| 02 Apr 2025 08:50 CEST |
PHOTOCURE | Photocure ASA: Transactions made under share buyback program | 20103015 Pharmaceuticals | Acquisition or disposal of the issuer’s own shares |
| 31 Mar 2025 22:48 CEST |
PHOTOCURE | Photocure ASA: Transactions made under share buyback program | 20103015 Pharmaceuticals | Acquisition or disposal of the issuer’s own shares |
| 26 Mar 2025 08:55 CET |
PHOTOCURE | Photocure ASA - Share option grant to Vice President and General Manager EMEA | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
| 26 Mar 2025 08:00 CET |
PHOTOCURE | Photocure appoints Jane Healy as Vice President and General Manager EMEA | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 24 Mar 2025 17:00 CET |
PHOTOCURE | Clinical data presentations at the European Association of Urology (EAU) 2025 congress highlight the benefits of using Blue Light Cystoscopy in bladder cancer | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 19 Mar 2025 18:00 CET |
PHOTOCURE | Photocure ASA: Initiation of a share buyback | 20103015 Pharmaceuticals | Acquisition or disposal of the issuer’s own shares |
| 14 Mar 2025 08:00 CET |
PHOTOCURE | New BRAVO Study Publication Reinforces Clinical Benefits of BLC in Reducing Risk of Bladder Cancer Recurrence | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 28 Feb 2025 15:51 CET |
PHOTOCURE | Photocure ASA – Major shareholding disclosure | 20103015 Pharmaceuticals | Major shareholding notifications |
| 28 Feb 2025 15:05 CET |
PHOTOCURE | NOTIFICATION OF MAJOR HOLDINGS | 20103015 Pharmaceuticals | Major shareholding notifications |
| 19 Feb 2025 08:00 CET |
PHOTOCURE | Photocure ASA: Results for the fourth quarter of 2024 | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 17 Feb 2025 17:00 CET |
PHOTOCURE | News on Richard Wolf/Photocure Collaboration: Interim Flexible BLC solution available in countries where System blue and Richard Wolf reusable flexible cystoscopes are cleared | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 17 Feb 2025 07:30 CET |
PHOTOCURE | Bladder Cancer: Upstaging and risk mitigation with Blue Light Cystoscopy in NMIBC featured at ASCO GU 2025 | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 12 Feb 2025 14:27 CET |
PHOTOCURE | Photocure ASA: Invitation to presentation of 4th quarter and preliminary full year 2024 financial results | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 16 Jan 2025 08:46 CET |
PHOTOCURE | Photocure ASA: Transactions made under share buyback program | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
| 13 Jan 2025 08:00 CET |
PHOTOCURE | Photocure ASA: Transactions made under share buyback program | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
| 05 Jan 2025 08:47 CET |
PHOTOCURE | Photocure ASA: Transactions made under share buyback program | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
| 23 Dec 2024 08:02 CET |
PHOTOCURE | Photocure ASA - Share option grant | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
| 19 Dec 2024 08:02 CET |
PHOTOCURE | Photocure ASA: Initiation of a share buyback | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 12 Dec 2024 10:16 CET |
PHOTOCURE | Financial calendar | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 03 Dec 2024 15:14 CET |
PHOTOCURE | Photocure ASA: Notification of primary insider transaction | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
| 03 Dec 2024 07:00 CET |
PHOTOCURE | Photocure ASA: Notification of primary insider transaction | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
| 13 Nov 2024 08:00 CET |
PHOTOCURE | Photocure ASA: Results for the third quarter of 2024 | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 06 Nov 2024 16:48 CET |
PHOTOCURE | Photocure ASA: Invitation to presentation of third quarter 2024 financial results | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 05 Nov 2024 10:34 CET |
PHOTOCURE | Photocure Partner Asieris announces Marketing Approval by the National Medical Products Administration for Hexvix in China | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 30 Sep 2024 08:00 CEST |
PHOTOCURE | Photocure Partner Asieris Unveils Cevira (APL-1702) Phase III Subgroup Analysis by Age Groups at the 2024 CSCO Annual Meeting | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 27 Sep 2024 08:00 CEST |
PHOTOCURE | Photocure establishes Named Patient Program to provide access to Hexvix in South Africa | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 17 Sep 2024 12:10 CEST |
PHOTOCURE | Cevira (APL-1702): Photocure Partner Asieris Unveils Efficacy Data of Non-Surgical Treatment of Cervical HSIL at the 2024 PDT&PD Conference | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 16 Sep 2024 11:17 CEST |
PHOTOCURE | Notification of major shareholding | 20103015 Pharmaceuticals | Major shareholding notifications |
| 07 Aug 2024 08:00 CEST |
PHOTOCURE | Photocure ASA: Results for the second quarter of 2024 | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 31 Jul 2024 12:00 CEST |
PHOTOCURE | Photocure ASA: Invitation to presentation of second quarter and first half year 2024 financial results | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 15 Jul 2024 17:52 CEST |
PHOTOCURE | Photocure and Richard Wolf Enter into Agreement to Develop a High-Definition Flexible Blue Light Cystoscope for Global Commercialization | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 04 Jun 2024 08:00 CEST |
PHOTOCURE | Photocure Announces Mobile BLC Tower Initiative to Expand Access to Cysview in the U.S. | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 23 May 2024 19:33 CEST |
PHOTOCURE | Photocure ASA - Annual general meeting held | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 15 May 2024 08:00 CEST |
PHOTOCURE | Photocure ASA: Results for the first quarter of 2024 | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 12 May 2024 10:24 CEST |
PHOTOCURE | Photocure Partner Asieris announces New Drug Application acceptance for regulatory review of Cevira in China | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 08 May 2024 22:36 CEST |
PHOTOCURE | Photocure ASA: Invitation to presentation of first quarter 2024 financial results | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 07 May 2024 08:00 CEST |
PHOTOCURE | Bladder Cancer: Long-Term Benefits of Blue Light Cystoscopy and Enhanced Detection with HD Technology Unveiled at AUA 2024 | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 30 Apr 2024 13:49 CEST |
PHOTOCURE | Photocure ASA - Notice of the Annual General Meeting 23 May 2024 | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 30 Apr 2024 11:52 CEST |
PHOTOCURE | Photocure ASA: Annual Report 2023 | 20103015 Pharmaceuticals | Annual financial and audit Reports |
| 30 Apr 2024 07:30 CEST |
PHOTOCURE | Bladder Cancer: pivotal trial results and new real-world evidence, to be presented at AUA 2024, demonstrate improved diagnostic and clinical outcomes with blue light cystoscopy | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 25 Apr 2024 21:53 CEST |
PHOTOCURE | Photocure ASA - Share option grant | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
| 08 Apr 2024 12:33 CEST |
PHOTOCURE | European Association of Urology (EAU) 2024 congress features new data on modern technology use in bladder cancer care | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 05 Apr 2024 07:30 CEST |
PHOTOCURE | Photocure to Participate in the 23[rd] Annual Needham Virtual Healthcare Conference | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 28 Mar 2024 13:14 CET |
PHOTOCURE | New Publication: Racial Difference in Detection Rate of Bladder Cancer Using Blue Light Cystoscopy | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 18 Mar 2024 10:05 CET |
PHOTOCURE | Photocure Partner Asieris announces positive international Phase III clinical trial results for Cevira and data presentations at the 2024 EUROGIN Congress and SGO Annual Meeting | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 23 Feb 2024 08:35 CET |
PHOTOCURE | Photocure Partner Asieris to Unveil Results of the international multicenter Phase III clinical Study for Cevira, a non-surgical treatment for cervical HSIL, at the 2024 SGO | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 22 Feb 2024 08:37 CET |
PHOTOCURE | Photocure Partner Asieris to present First-ever Results of the international multicenter Phase III clinical Study for Cevira, a non-surgical treatment for cervical HSIL, at the 2024 EUROGIN | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 21 Feb 2024 08:00 CET |
PHOTOCURE | Photocure ASA: Results for the fourth quarter of 2023 | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |